# Artificial Intelligence for Early Detection and Prediction of Chronic Obstructive Pulmonary Disease Exacerbations

## TL;DR

AI can detect COPD flare-ups early by combining health data and environmental factors, enabling timely and personalized care.

## Contribution

AI models reveal early deterioration patterns, environmental sensitivity phenotypes, and novel spirometry biomarkers for COPD exacerbations.

## Key findings

- Physiological and behavioral changes precede COPD exacerbation symptoms by 7–14 days.
- ML models identify COPD phenotypes with distinct environmental sensitivity and medication adherence interactions.
- Deep learning of spirometry data uncovers structural phenotypes and imaging biomarkers beyond FEV1.

## Abstract

What are the main findings?
Studies consistently show that combining frequent health data with contextual information improves the early detection of COPD exacerbations.Explainable Artificial Intelligence (AI) approaches help clarify why risk increases, revealing early warning patterns and meaningful differences in how patients respond to environmental exposures.

Studies consistently show that combining frequent health data with contextual information improves the early detection of COPD exacerbations.

Explainable Artificial Intelligence (AI) approaches help clarify why risk increases, revealing early warning patterns and meaningful differences in how patients respond to environmental exposures.

What are the implications of the main findings?
For AI tools to be useful in practice, COPD exacerbations must be defined consistently, and models must be validated across diverse patient populations and care settings.When designed with clinical workflows in mind, interpretable AI systems could support earlier intervention and more personalized COPD management.

For AI tools to be useful in practice, COPD exacerbations must be defined consistently, and models must be validated across diverse patient populations and care settings.

When designed with clinical workflows in mind, interpretable AI systems could support earlier intervention and more personalized COPD management.

Background: Exacerbations of chronic obstructive pulmonary disease (COPD) are a leading cause of morbidity, mortality, and healthcare burden worldwide. Early detection and timely intervention remain important challenges in COPD management, given the unpredictable nature of acute deterioration and limitations of traditional spirometry-based risk assessment. Methods: This narrative review synthesizes artificial intelligence (AI)-driven approaches for predicting and detecting chronic obstructive pulmonary disease (COPD) exacerbations across electronic health records, wearable sensors, imaging, environmental data, and patient-reported outcomes, emphasizing novel discoveries and emerging relationships rather than predictive performance. Results: Three major discoveries have been made. First, measurable physiological and behavioral deterioration may precede symptom recognition by approximately 7–14 days, thereby establishing a potential intervention window for anticipatory care. Second, machine learning (ML) models integrating pollutant exposure, medication adherence, and clinical characteristics have identified phenotypes with differential environmental sensitivity, including unexpected exposure–adherence interactions. Third, deep neural network analysis of full spirometry curves has revealed structural phenotypes beyond traditional Forced Expiratory Volume (FEV1)-based measures and novel imaging biomarkers. The predictive performance ranges from the Area Under the Curve (AUC) 0.72–0.95, with a pooled meta-analytic AUC of approximately 0.77. Conclusions: AI has uncovered hidden patterns in the progression of COPD, supporting a shift from reactive to anticipatory management. Translation to routine care requires prospective validation, improved interpretability, workflow integration, and generalizability and equity.